Browse Biological products industry topic

Reports subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Research and Markets: Research Report on the Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010. Report Dec 10, 2009 360 Research and Markets: Drug Price/Cost Debate: Growing Pricing Pressures: Swine Flu Vaccine, Profiteering, Comparison of Drug Prices in Different Countries, Free Pricing Markets, Generic Pricing. Nov 17, 2009 845 Vitro to Expand Manufacturing Capacity & Report Increased Product Sales for 2009. Nov 10, 2009 646 Research and Markets: China Blood Products Industry Report 2009 Reveals - Hualan Biological Engineering Inc's Total Profit in 2008 was RMB218 Million. Report Oct 22, 2009 456 Research and Markets: A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry. Report Oct 22, 2009 443 WWF report: Industrial biotech can save the world up to 2.5 billion tons of CO2 per year. Sep 18, 2009 688 Zacks Analyst Blog Highlights: Novavax, AstraZeneca, GlaxoSmithKline, Novartis and Sanofi-Aventis. Sep 3, 2009 761 Research and Markets: 2009 Worldwide Biological Product Manufacturing Industry Report with 2010 Forecasts and 5 Years of Historical Trends. Report Aug 28, 2009 249 Merriman Curhan Ford Initiates Coverage on Helix BioPharma. Aug 3, 2009 913 Reportlinker Adds Autoimmune Disease Therapeutics. Jul 16, 2009 3090 Reportlinker Adds Bioterrorism. Jul 16, 2009 1562 Research and Markets: Biopharma Quarter - Key Trends and Events of the First Quarter of 2009. Jul 15, 2009 438 Merriman Curhan Ford Initiates Coverage on Repligen Corporation. Jul 1, 2009 1069 Leerink Swann's Partnering & Acquisitions for Commercial Stage Biopharmaceuticals Investment Analysis Now Available. Jun 30, 2009 385 Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015. Jun 4, 2009 3085 Biogen Idec Comments on Proxy Advisory Firms' Reports. May 24, 2009 690 Zacks Analyst Blog Highlights: Bank of America, Citigroup, Microsemi Corp., Acorda Therapeutics, Inc. and Web.com. Company overview May 7, 2009 808 FDA cites CSL for 14 violations in vaccine manufacturing operations. May 1, 2009 964 CSL fails to take proper corrective actions. Mashaw, Rebecca May 1, 2009 967 Study Highlights Economic Impact of Early Mobility Impairment in People with Multiple Sclerosis. Apr 29, 2009 805 Research and Markets: Evolving Trends in Biopharmaceutical Licensing - Deal Assessments, Drivers and Resistors. Apr 6, 2009 869 Research and Markets: Product Pinpoint: The New Vaccines - Report Available Now. Apr 6, 2009 190 Research Report on Global and Chinese Blood Product Industry, 2009. Report Mar 26, 2009 1854 Research and Markets: The 2009 U.S. Biological Product Manufacturing Industry Report Finally Available. Report Mar 9, 2009 245 Research and Markets: Gene Therapy - A Strategic Business Report 2009. Report Mar 3, 2009 136 NVIC Says BMJ Review Demonstrates Medical Journal Bias Toward Pharma-Sponsored Influenza Vaccine Studies. Feb 12, 2009 344 Research and Markets: Novartis: Performance - Products - Pipeline - Potential - Report Available Now. Company overview Feb 4, 2009 475 Research and Markets: Report 'Chinese Markets For Biopharmaceuticals' Provides Historical Data (1998, 2003 And 2008) and Long-Term Forecasts Through To 2013 and 2018. Jan 30, 2009 182 Research and Markets: Unique Martek Biosciences Corporation and the U.S. Biological Product (Except Diagnostic) Manufacturing Industry Report Now Available. Jan 29, 2009 427 Roche, Genentech and Merck Tipped for Strong Growth in Cancer Markets Says Report from URCH Publishing. Jan 16, 2009 389 Dawson James Securities Initiates Research Coverage of StemCells, Inc. With Buy Recommendation. Jan 14, 2009 633 Research and Markets: China Blood Products Industry Report, 2007-2008 Out Now. Report Jan 9, 2009 321 Get a Deep Insight into the World Gene Therapy Market. Dec 16, 2008 1796 High Growth Reported for the China Vaccine. Dec 11, 2008 162 Vitrolife: Interim Report January-September 2008. Oct 22, 2008 750 Research and Markets: China Company Research - Beijing Tiantan Biological Products Co., Ltd. Report Out Now. Sep 10, 2008 520 ONN Sidewinder Video Report: AIG Hammered Following Earnings. Aug 7, 2008 155 ONN Sidewinder Video Report: SunTrust on the Rebound. Jul 21, 2008 153 Research and Markets: Company Report of China's Hualan Biological Engineering Inc. Report Jul 11, 2008 344 Dutton Associates Announces Investment Opinion: Amarin Rating Maintained At Speculative Buy By Dutton Associates. Jun 24, 2008 489 New Report 'Clinical Stage Partnering Agreements in Biopharma' Provides a Detailed Understanding and Analysis of How and Why Companies Enter Clinical Stage Partnering Deals. Jun 5, 2008 1111 Research and Markets: This Report Is An Insightful Source For Data, Analysis And Strategic Insights Into Osteotech, Inc.'s Pipeline And Investigational Products. Jun 4, 2008 40 The Sidewinder Report: Traders repositioning Focus Media Holding Options. Jun 2, 2008 137 Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies. Mar 24, 2008 656 ISS Recommends Vote Against VaxGen Proposals--Applauded by MedCap. Mar 20, 2008 361 Zacks Analyst Interview Highlights: Genentech, Amgen and Biogen. Feb 26, 2008 481 Dutton Associates Announces Investment Opinion: Sinobiomed Strong Speculative Buy Rating In Initiating Coverage By Dutton Associates. Feb 19, 2008 462 Dutton Associates Announces Investment Opinion: Amarin Rating Raised To Speculative Buy By Dutton Associates. Jan 25, 2008 438 Vaccines Market Insight Report Examines the Size and Value of the Vaccine Market as It is Today. Jan 14, 2008 433 The Genentech Inc Product Pipeline Report Delivers The Latest And The Most Comprehensive Intelligence Available On Genentech Incs Current Pipeline Portfolio. Report Dec 11, 2007 239 Advanced Tissue Sciences Inc Deals & Alliances Report. Report Dec 7, 2007 297 Research and Markets: Study the Latest Product Pipeline Information on BioTime Inc with New Report. Report Nov 26, 2007 238 Research and Markets: New Report Examines the Latest Product Pipelines on Cell Genesys Inc. Report Nov 23, 2007 242 Enzo Biochem, Inc. (ENZ) to Be Featured on the Corporate-Strategies Radio Show Friday at 10:30 Eastern Time, 7:30 Pacific Time by a Lazard Capital Markets Analyst. Nov 8, 2007 121 Reportlinker.com: Get a Deep Insight into Genentech's Strategy in the Ethical Pharmaceutical Sector. Oct 22, 2007 736 Research and Markets: Otsuka Dealmaking Profile Provides an in Depth Insight into the Dealmaking Activity of One of the Worlds Leading Biopharma Companies. Oct 8, 2007 552 Research and Markets: Gilead Sciences Report Provides an in-Depth Insight into the Dealmaking Activity and Interests of One of the World's Leading Biopharma Companies. Report Oct 5, 2007 476 Research and Markets: New Competitor Report Analyzes Developments at Tutogen Medical Inc. Report Sep 28, 2007 217 Vaccine firm denies breach; Prime Minister awaits HSE report into outbreak. Aug 6, 2007 362 Research and Markets: Gain an Insight Into Biogen Idec, Inc. Jul 16, 2007 210 China Blood Product Industry Report, 2006-2007 Is Available Now. Jul 13, 2007 453 BullMarket.com Offers Investment Opinion on Sprint, Alvarion, DivX, and Medarex. May 3, 2007 373 Research & Markets: Gilead Sciences Acquisitions of Myogen and Corus Pharma Has Significantly Expanded the Scope of Their Research Efforts. Apr 19, 2007 522 Zacks Bull and Bear of the Day Highlights: Amphenol Corporation, Acorda Therapeutics, Synopsys and Tractor Supply. Apr 13, 2007 1002 New One-Year Pharmacoeconomic Study Shows AVONEX(R) is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis. Apr 13, 2007 742 BullMarket.com Offers Investment Opinion on Research In Motion, Genentech, Amgen, and DivX. Apr 13, 2007 430 Gilead receives 3-item 483 for faulty test methods. Apr 1, 2007 1018 3-item 483 handed to Gilead Sciences for improper validation protocol. Apr 1, 2007 769 New Report Profiles 144 Companies Operating in the Global Blood Banking & Blood Products Industry. Mar 28, 2007 416 Dutton Associates Announces Investment Opinion: Amarin Rating Maintained At Strong Speculative Buy By Dutton Associates. Feb 28, 2007 405 Vanguard Equity Research Corp Announces Investment Opinion: Vanguard Equity Research Corp Initiates Coverage on Skystar Bio-Pharmaceutical with a Buy Rating and a $2.75 Price Target. Feb 27, 2007 633 Research and Markets: Novozymes - Company Profile Identifies And Analyzes The Company's Strength And Weaknesses To Come Up With The Possible Opportunities For The Company. Feb 22, 2007 328 Research and Markets: Biogen Idec Inc - Deals And Alliances Report Delivers The Latest And The Most Comprehensive Intelligence Available On Biogen Idec Incs Partnerships And M&A Activity. Feb 16, 2007 291 Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Biomira, Inc. With A Market Outperform Rating. Feb 15, 2007 328 Research and Markets: AVANT Immunotherapeutics Inc - Deals and Alliances Report Provides an Unbiased, Accurate, Independent Approach to Company Analysis, Whether for Partnering or Investment Purposes. Feb 6, 2007 291 Research and Markets: The CEL-SCI Corporation Competitor Report Provide An Unbiased, Accurate, Independent Approach To Company Analysis, Whether For Partnering Or Investment Purposes. Jan 29, 2007 210 TB4 is Essential for Coronary Vessel Development Report U.K. and U.S. Scientists. Nov 17, 2006 740 Study Suggests Lp-PLA2 Plays a Causal Role in Plaque Instability and Subsequent Sudden Coronary Death. Nov 1, 2006 470 Dutton Associates Announces Investment Opinion: CEL-SCI Speculative Buy Rating in Initiating Coverage by Dutton Associates. Oct 24, 2006 454 Study Shows Inflammatory Enzyme Lp-PLA2 Predicts Recurrent Stroke. Oct 24, 2006 633 Zacks Earnings Preview: Alcoa, First Niagara Financial Group, Gannett, Genentech and Host Hotels & Resorts. Oct 9, 2006 1119 New England Journal Report: Bascom Palmer Specialist's Study Shows Significant Vision Improvement for Patients with Wet AMD. Clinical report Oct 4, 2006 1025 QUEST DIAGNOSTICS EARNS TOP RANKING FOR ITS CHARTMAXX. Oct 1, 2006 892 New Study: AVONEX(R), The Most Prescribed Multiple Sclerosis Treatment Worldwide, Demonstrates Superior Adherence. Sep 28, 2006 959 Wall Street Advisor Initiates Coverage on DOR BioPharma, Inc. with a Speculative Buy Recommendation. Sep 28, 2006 202 Wall Street Advisor Initiates Coverage on DOR BioPharma, Inc. (OTCBB: DORB.OB) with a Speculative Buy Recommendation. Sep 26, 2006 179 AVANT Announces Latest GSK Report on Sales of Rotarix(R) Evidences Disagreement on Royalty Rate in Patent Countries. Sep 20, 2006 834 Windhover Information's FDA/CMS Summit for BioPharma Executives: Commercial Success in the Regulatory Environment; Pfizer's Feczko to Address FDA Impact on Drug Development. Sep 8, 2006 708 Windhover Information's FDA/CMS Summit for BioPharma Executives: Commercial Success in the Regulatory Environment; Loucks, Woodcock among Eminent Speakers; December 4-5, 2006 JW Marriott Pennsylvania Ave., Washington, DC. Aug 25, 2006 1208 Report reveals skills shortage. Aug 16, 2006 306 Schaeffer's Daily Market Blog Features: Ford Motor, General Motors, Merck, Gilead Sciences, and Genesis Microchip. Aug 14, 2006 868 Panel Recommends Values for Lp-PLA2 in the Assessment of Cardiovascular Disease Risk; diaDexus' PLAC(R) Test Predicts Risk of Heart Disease and Stroke. Aug 1, 2006 478 Dutton Associates Announces Investment Opinion: Amarin Rating Raised To Strong Speculative Buy By Dutton Associates. Jul 25, 2006 417 Dutton Associates Announces Investment Opinion: MorphoSys AG Strong Speculative Buy Rating In Initiating Coverage By Dutton Associates. May 24, 2006 478 Market Forecasts to 2016 for the Fast Growing Chemotherapy Market. May 19, 2006 834 Zacks.com Announces That the Following Companies Will Release Earnings This Week: Genentech, Circuit City, Harley-Davidson, Lam Research and Tribune Co. Apr 11, 2006 1066 BioSante Pharmaceuticals Presents New Anthrax Vaccine Data at World Vaccine Congress. Mar 22, 2006 891 Schaeffer's Daily Market Blog Features Quanex, IBM, AVI BioPharma, M.D.C. Holdings, and PHAZAR. Jan 17, 2006 1212 PCR-based test speeds detection of mycoplasma contaminants: Genentech. Faden, Mike Jan 1, 2006 434 OOS results, media hold-time specifications, flawed validation reports net IDEC 10-item 483. Pickett, Joseph Jun 1, 2005 434